Latest

Coronavirus

Featured Neuroscience

·March 24, 2020·2 min read

Lying face down improves breathing in severe COVID-19

A small study of patients with severe COVID-19 symptoms in Wuhan found laying face down was better for the lungs.

Featured Neuroscience

·March 24, 2020·3 min read

COVID-19: Now is not the time to ease social distancing measures

Despite talk of re-opening the country to boost the economy, public health officials are urging the public to remain at home and socially distance to slow the spread of COVID-19. They warn that if we don't, the spread will get worse, and death rates will rise.

Featured Neuroscience

·March 24, 2020·5 min read

Repurposing blood clot drug could help treat COVID-19

Tissue plasminogen activators (tPA), FDA approved drugs used to treat stroke and heart attack patients, may help COVID-19 patients in danger of respiratory failure. If successful, the drug may help treat severe respiratory symptoms when ventilators are not available.

This shows a social distancing nice meme

Featured Neuroscience Open Neuroscience Articles

·March 24, 2020·7 min read

Singapore modeling study estimates impact of physical distancing on reducing spread of COVID-19

Singapore model indicates quarantining people infected with COVID-19 and their family members, closing schools, and distancing, in that order, are effective at reducing transmission of the virus.

Featured Neuroscience Neuroscience Videos

·March 24, 2020·9 min read

DIY medical devices and protective gear fuel battle against COVID-19

Georgia Tech researchers are using 3D printing, plastic-lined table cloths, and an array of other items to craft personal protective equipment that can be used by healthcare workers treating COVID-19 patients. The team will share the designs for free, allowing for crowdsourcing of DIY protective gear.

Featured Neuroscience Open Neuroscience Articles

·March 23, 2020·2 min read

ACE inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19

Researchers confirm ACE inhibitors and ARBS medications may increase the risk of patients with COVID-19 developing more severe symptoms.

Featured Neuroscience

·March 23, 2020·4 min read

Containment efforts appear to step COVID-19 spread down from exponential norm

Community actions taken to slow the spread of COVID-19 may help to contain the virus and stop the exponential growth of cases. Researchers say the viral spread in China occurred in a fractal pattern. When social distancing was implemented, viral spread slowed. With more communities adopting social distancing measures, the spread became smaller in each new area exposed.

Featured Neuroscience Open Neuroscience Articles

·March 23, 2020·4 min read

COVID-19 pandemic likely to go in waves

A new mathematical model shows the current COVID-19 pandemic could decline during the summer months, but return in the fall, with a major resurgence next winter. The model takes into account the seasonal variations of other closely related respiratory coronaviruses. Based on other coronavirus data, the model reveals infections were ten times more common between December and April in the northern hemisphere than between July and September. Researchers emphasize this model only attempts to examine possible scenarios, as we are currently unsure how warmer temperatures will affect SARS-CoV-2.

Featured Neuroscience

·March 23, 2020·3 min read

Tuberculosis BCG-based vaccine may be effective against COVID-19

VPM1002, a vaccine candidate based on the tuberculosis BCG vaccine, may be effective in protecting against COVID-19. Previous studies in mice have shown the BCG vaccine is effective at protecting against several respiratory viral infections. If effective against coronavirus, researchers hope the vaccine can bridge the time gap until a specific SARS-CoV-2 vaccine is available.

Featured Neuroscience

·March 23, 2020·1 min read

Loss of smell sense first sign of COVID-19

As many as one in three COVID-19 patients report smell loss as an early symptom of the infection. Researchers say the loss of smell could be used as a key clinical indicator of infection in otherwise symptom-free or pre-symptomatic carriers of coronavirus.

Featured Neuroscience

·March 21, 2020·2 min read

New vaccine candidate for COVID-19 identified

Researchers report they have identified a vaccine candidate for COVID-19 and are working towards phase one clinical testing. A chimpanzee adenovirus vaccine vector was chosen as the most suitable vaccine technology for SARS-CoV-2 as it can generate a stronger immune response in one dose and is not a replicating virus.

This shows the structure of the protease

Featured Genetics Neuroscience Open Neuroscience Articles

·March 20, 2020·2 min read

COVID-19: Main protease of SARS-CoV-2 decoded

Researchers have decoded the 3-D architecture of the main SARS-CoV-2 protease. The protein is involved in the reproduction of the virus. The findings may help in the systematic development of drugs to inhibit the reproduction of the virus, potentially lowering COVID-19 infections.